AliveDx anuncia la presentación a la FDA de la solicitud 510 para el microensayo multiplex MosaiQ AiPlex®

AliveDx Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom California United States of America Europe

View original content:https://www.prnewswire.com/news-releases/alivedx-anuncia-la-presentacion-a-la-fda-de-la-solicitud-510k-para-el-microensayo-multiplex-mosaiq-aiplex-302371804.html